Biomedicines: 10th Anniversary
A special issue of Biomedicines (ISSN 2227-9059).
Deadline for manuscript submissions: closed (30 November 2023) | Viewed by 121411
Special Issue Editor
2. Vascular Vision Pharmaceuticals Co., Rensselaer Polytechnic Park, Troy, NY 12180, USA
Interests: pharmaceuticals; biopharmaceuticals and diagnostics; nanomedicine; cardiovascular diseases; neurological disorders; hematology and oncology; biosimilar and nanosimilar; angiogenesis; inflammation; thrombosis; integrin and cell adhesion molecules; target identification; molecular mechanisms and signaling pathways; preclinical; clinical; marketing and post marketing studies; regulatory and ethical issues
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The year 2023 marks the 10th anniversary of Biomedicines, a peer-reviewed, open access journal containing research relevant to the field of biomedicine. Biomedicines (ISSN 2227-9059) is an open access journal devoted to all aspects of research on human health and disease, the discovery and characterization of new therapeutic targets and therapeutic strategies, and naturally driven biomedicines, pharmaceuticals, and biopharmaceutical products. Biomedicines was accepted for coverage in the Science Citation Index Expanded (SCIE)—Web of Science (Clarivate Analytics) in 2019, starting from Volume 7, and received its first IF of 4.717 in 2020. It obtained a 2021 IF of 6.081, ranking 32 out of 140 (Q1) titles in the 'Medicine, Research & Experimental' category, 32 out of 275 (Q1) titles in 'Pharmacology & Pharmacy', as well as 65 out of 298 (Q1) titles in 'Biochemistry & Molecular Biology'.
To date, nearly 3000 papers have been published in Biomedicines, from more than 17000 authors, and 246 peer-reviewed articles have been cited 10 or more times (data up to 2 December 2021). We would like to sincerely thank our readers, innumerable authors, anonymous peer reviewers, editors, and all of the individuals who work for the journal in some way, and who have contributed time and effort throughout the years. These highlights would not have been possible without your participation.
To celebrate this significant milestone, a Special Issue entitled “Biomedicines: 10th Anniversary” has been launched. This Special Issue will include high-quality papers on topics within the broad scope of Biomedicines. It is our pleasure to invite you to contribute an original research paper or a comprehensive review article on a current, trending topic for peer review and possible publication in Biomedicines.
Prof. Dr. Shaker A. Mousa
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
Related Special Issues
- 10th Anniversary of Biomedicines—Biomarkers in Pain in Biomedicines (11 articles)
- 10th Anniversary of Biomedicines—Aging Changes in Cells, Tissues and Organs in Biomedicines (5 articles)
- 10th Anniversary of Biomedicines—Ophthalmology Disorders in Biomedicines (13 articles)
- 10th Anniversary of Biomedicines—Advances in Proteinases and Proteinase Inhibitors in Biomedicines (7 articles)
- 10th Anniversary of Biomedicines—3D In Vitro Models as an Alternative to Animal Experimentation: Advantages and Pitfalls in Biomedicines (5 articles)
- 10th Anniversary of Biomedicines: Mechanisms and Novel Therapeutic Approaches for Brain Cancer in Biomedicines (5 articles)
- 10th Anniversary of Biomedicines—from Inflammation to Fibrosis: Implications of Human Diseases in Biomedicines (4 articles)
- 10th Anniversary of Biomedicines—Molecular Mechanisms and Treatments on Neurodegenerative Diseases in Biomedicines (5 articles)
- 10th Anniversary of Biomedicines—Advances in Tendon and Bone Regeneration in Biomedicines (4 articles)
- 10th Anniversary of Biomedicines—Advances in Chronic Obstructive Pulmonary Disease (COPD) in Biomedicines (5 articles)
- 10th Anniversary of Biomedicines—Recent Advances on Adipokines in Biomedicines (23 articles)
- 10th Anniversary of Biomedicines-Immunopathogenesis of Autoimmune Diseases in Biomedicines (4 articles)
- 10th Anniversary of Biomedicines—Advances in Endothelial Dysfunction in Biomedicines (15 articles)
- 10th Anniversary of Biomedicines—NAFLD: From Mechanisms to Therapeutic Approaches in Biomedicines (12 articles)
- 10th Anniversary of Biomedicines—Sepsis: Diagnostics and Therapeutics in Biomedicines (13 articles)
- 10th Anniversary of Biomedicines: The Development of Cancer Immunotherapy in Biomedicines (14 articles)
- 10th Anniversary of Biomedicines—Advances in New Pharmacological Therapies in Biomedicines (12 articles)
- 10th Anniversary of Biomedicines: Neuroinflammation and Neuroprotection in Biomedicines (10 articles)
- 10th Anniversary of Biomedicines—Advances in Mesenchymal Stem Cells in Biomedicines (5 articles)
- 10th Anniversary of Biomedicines—Advances in Cancer Invasion and Metastasis in Biomedicines (3 articles)
- 10th Anniversary of Biomedicines—Advances in Prostate Cancer: Science Discovery, Drug Resistance, Biomarkers, and Beyond in Biomedicines (16 articles)
- 10th Anniversary of Biomedicines—Translational Laboratory and Experimental Medicine for the Sake of Neurological Diseases and Mental Illnesses in Biomedicines (22 articles)
- 10th Anniversary of Biomedicines—Induced Pluripotent Stem Cells: 15 Years after the Discovery in Biomedicines (4 articles)
- 10th Anniversary of Biomedicines—Advances in Wound Repair and Regeneration in Biomedicines (6 articles)
- 10th Anniversary of Biomedicines—Genetics of Cholesterol in Cardiovascular Disease: From Basics to Clinics in Biomedicines (4 articles)
- 10th Anniversary of Biomedicines—Novel Targets for Cranial Tumors in Biomedicines (5 articles)
- 10th Anniversary of Biomedicines—Advances in Multiple Sclerosis in Biomedicines (8 articles)